首页> 外文期刊>Journal of Ophthalmology >Early Refractive and Clinical Outcomes of High-Myopic Photorefractive Keratectomy as an Alternative to LASIK Surgery in Eyes with High Preoperative Percentage of Tissue Altered
【24h】

Early Refractive and Clinical Outcomes of High-Myopic Photorefractive Keratectomy as an Alternative to LASIK Surgery in Eyes with High Preoperative Percentage of Tissue Altered

机译:高近视光折变形术的早期屈光和临床结果作为Lasik手术的眼睛中的替代品,具有高术前百分比的组织改变

获取原文
           

摘要

Objective. To analyze the safety and efficacy of high-myopic PRK as an alternative to LASIK surgery in patients with a high preoperative percentage tissue altered (PTA). Design. Retrospective interventional case series. Participants. Charts of 256 consecutive eyes that underwent PRK with application of mitomycin-C 0.02% for high myopia were retrospectively reviewed. Methods. Refractive (refraction and refractive accuracy) and visual outcomes (uncorrected and corrected visual acuities), as well as occurrence of haze in the eyes with preoperative PTA expected to be higher than 40% with a 110-micron flap if undergoing LASIK surgery, were analyzed. Results. Mean follow-up was 7.3?±?4.8?months. A total of 187 of 256 eyes (73.0%) were included in the analysis because they were expected to have a PTA greater than 40%, should they have undergone LASIK surgery. The actual mean PTA of those eyes following PRK was 31.8?±?2.2%, and none had a PTA?≥?40%. UDVA of 20/16, 20/20, and 20/25 or better was achieved in 1.2% (2 eyes), 65.5% (112 eyes), and 85.4% (146 eyes), respectively. The percentage of eyes with postoperative SE within ±0.5?D and ±1.0?D of planned SE was 71% and 93%, respectively. None of the eyes lost 2 or more lines of CDVA. The rate of stromal haze, managed successfully with topical steroids only, was 4.8%. Conclusion. High-myopic PRK with application of mitomycin-C in the eyes at risk of developing ectasia because of high preoperative PTA was demonstrated to be a safe and effective alternative to the LASIK procedure.
机译:客观的。分析高近视性PRK作为患有高术前百分比组织(PTA)的患者LASIK手术的替代品的安全性和疗效。设计。回顾性的介入案例系列。参与者。回顾性地审查了256次连续眼睛,含有丝裂霉素-C-C 0.02%的丝霉素-C-C 0.02%的表达的图表。方法。折射(折射和折射精度)和视觉结果(未校正和矫正的视觉抗体)以及预期PTA的眼睛中的雾度的发生,预计如果接受LASIK手术,则预期高于40%,如果发生了110微米的襟翼,则进行了110微米的襟翼。 。结果。平均随访是7.3?±4.8?几个月。在分析中,共有187名中的187只(73.0%),因为它们预计它们是否有超过40%的PTA,它们是否应该经历LASIK手术。 PRK之后的那些眼睛的实际平均PTA是31.8?±2.2%,没有PTA?≥?40%。在1.2%(2只眼),65.5%(112只眼)和85.4%(146只眼)中实现了20/16,20 / 20和20/25或更好的UDVA。垂直于±0.5〜d和±1.0'd的术后Se的眼睛的百分比分别为71%和93%。没有眼睛丢失了2个或更多的CDVA行。基质雾度率,仅用局部类固醇成功管理为4.8%。结论。高近视PRK在眼睛中施用丝裂霉素-C,由于高术前PTA而产生斑块的风险,这是对LASIK程序的安全有效的替代品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号